PerkinElmer Life Sciences

BioFocus DPI

Chesterford Research Park
Saffron Walden,
Essex,
CB10 1XL
United Kingdom

Tel: +44 (0) 1799 533 500
Fax: +44 (0) 1799 531 495

Print Email to a friend

BioFocus DPI’s StarDrop software suite enables the efficient design, identification and prioritization of compounds to achieve an optimal balance of properties at all stages of drug discovery. The package’s unique compound prioritization framework means that in silico predictions can be integrated with data from other sources such as in vitro and in vivo experiments to aid effective decision making.

Further Information: http://www.biofocus.com/stardrop



Related Products

BioFocus DPI Launches Six new SoftFocus Libraries
The new libraries contain novel, drug-like compounds that specifically target ion channels, kinases and proteases.



Related news from our archive

DiscoveRx and BioFocus Announce Co-marketing Agreement for GPCR Screening
The agreement allows BioFocus to perform screening on behalf of BioFocus’ customers using validated cell lines and associated detection platform.

BioFocus DPI and Procter & Gamble Sign Compound Management Agreement
BioFocus DPI announced today that it has signed a three year compound management agreement with Procter & Gamble Co. (P&G).

BioFocus DPI and Oncodesign Alliance to Provide Integrated Oncology Drug Discovery Services
BioFocus DPI and Oncodesign have joined forces to offer a comprehensive oncology drug discovery service.